EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSCCRG00000064152
Gene Symbol: GRIA4B
1 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSCCRG00000014189
Gene Symbol: GRIN1A
1 Cross references
202 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSCCRG00000020049
Gene Symbol: GRIN1A
1 Cross references
202 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1b

Ensembl ID : ENSCCRG00000018017
Gene Symbol: GRIN1B
1 Cross references
149 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1b

Ensembl ID : ENSCCRG00000022565
Gene Symbol: GRIN1B
1 Cross references
149 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSCCRG00000079098
Gene Symbol: GRIN2BB
1 Cross references
253 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSCCRG00000068265
Gene Symbol: GRIN2BB
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5

Ensembl ID : ENSCCRG00000050777
Gene Symbol: GRIK5
1 Cross references
285 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5

Ensembl ID : ENSCCRG00000038082
Gene Symbol: GRIK5
1 Cross references
285 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSCCRG00000040374
Gene Symbol: GRM2B
1 Cross references
207 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSCCRG00000037972
Gene Symbol: GRM2B
1 Cross references
207 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSCCRG00000004232
Gene Symbol: GRM3
1 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).